In their evaluation, the Committee will consider the following criteria:
Criterion 1: Evaluation of the Applicant
- Potential for a career working at the interface of cardiovascular disease and viral infection (HIV, HCV, HBV), metabolic disorders (e.g. nonalcoholic steatohepatitis), rheumatic autoimmune diseases, or inflammatory bowel disease.
- Academic record
- Prior research experience and/or publications
- Clearly written presentation supporting the research need
Criterion 2: Scientific Environment and Institutional Support
- Letter of Support from the Division Chief or Department Chair which confirms that the proposed scientific environment will contribute to the probability of success and that the institution is willing and able to commit sufficient resources for the conduct of the proposed research, including sufficient projected time.
Criterion 3: Evaluation of the Proposal
- Innovation and Significance: Is the proposed research new and original, and does it address an important question/issue related to cardiovascular disease or pulmonary arterial hypertension and one of the following areas: viral infection (e.g. HIV, HCV, HBV), metabolic disorders (e.g. nonalcoholic steatohepatitis), rheumatic autoimmune diseases (e.g., RA, SLE), or inflammatory bowel disease? Will the study advance concepts, methods, and/or technologies related to research in cardiovascular comorbidities in individuals affected by the above conditions?
- Approach: Are the conceptual framework, design, methods, and analyses adequately developed, well-integrated, well-reasoned, feasible (as determined by preliminary data or the expertise available), and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative tactics?
- Feasibility: Can the project, as described in the submitted proposal and budget, be accomplished within the timeframe of the award?